Clinical Trial Results:
A randomised, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of 500µg of GW799943X administered once-daily in the morning, 500µg of GW799943X administered once-daily in the evening, and 1000µg GW799943X administered once-daily in the morning compared with placebo and fluticasone propionate 250µg twice daily, all delivered by ROTADISK/DISKHALER for 28 days in subjects with persistent bronchial asthma symptomatic on low-dose ICS.
Summary
|
|
EudraCT number |
2004-005058-30 |
Trial protocol |
CZ DE |
Global completion date |
13 Jul 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 Dec 2018
|
First version publication date |
16 Dec 2018
|
Other versions |
|
Summary report(s) |
Cancelled before Active Statement |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.